The accumulation of toxic tau in the brain correlates significantly with synapse loss, impaired neuronal function, and cognitive decline in Alzheimer’s disease (AD) and other heterogeneous tauopathies. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.